Rest-Of-Latin-America Protein Expression Market Size, Share,Trends, Growth Analysis Report, 2031

Name: Rest-Of-Latin-America Protein Expression Market Size, Share,Trends, Growth Analysis Report, 2031
Creator: MarketsandMarkets

Overview Request Sample Pages Request Customization Download PDF

You are viewing: Rest Of Latin America Protein Expression Market analysis

Part of: Protein Expression Market (Global)

The Rest Of Latin America Protein Expression Market was valued at $46.9 Million in 2026 and projected to reach to $66.2 Million by 2031, representing a compound annual growth rate of 7.1%. Rest Of Latin America's protein expression market is positioned for sustained growth as emerging economies increasingly invest in biotechnology infrastructure and research capabilities.

Rest Of Latin America Protein Expression Market (2026-2031) : Size and Share

CAGR of

USD Million

Rest Of Latin America Protein Expression Market Trends and Insights

This region demonstrates a compound annual growth rate of 7.1%, reflecting increasing investment in biotechnology research and pharmaceutical development across emerging economies.
Rest Of Latin America is capitalizing on growing demand for recombinant proteins, monoclonal antibodies, and therapeutic biologics, driven by rising healthcare expenditures and expanding research infrastructure. The protein expression market in Rest Of Latin America is supported by improving access to advanced expression systems and growing collaboration with international biotech firms.
Rest Of Latin America's market growth is underpinned by regulatory improvements and increased adoption of mammalian and microbial expression platforms.
Between 2026 and 2031, Rest Of Latin America is expected to see accelerated adoption of protein expression technologies in contract research organizations and academic institutions, positioning the region as an emerging hub for biologics manufacturing and development..

Key Market Statistics

CAGR (2026-2031) 7.1% CAGR
Market Size, 2026 ~USD 46.9 Million
Forecast, 2031 ~USD 66.2 Million
Country Rest Of Latin America

Rest Of Latin America Protein Expression Market Overview

Market Valuation Growth :

Rest Of Latin America's protein expression market is valued at $46.9 million in 2026, with projections reaching $66.2 million by 2031, representing a robust 41% expansion over the forecast period.

Regional CAGR Performance :

The region maintains a steady 7.1% CAGR through 2031, slightly below the global average of 8.3%, indicating emerging market maturation and increasing biotechnology infrastructure development across Latin American economies.

Biotechnology Investment Surge :

Rest Of Latin America is experiencing increased capital allocation toward biotechnology research and pharmaceutical development, driven by government initiatives and private sector expansion in emerging economies.

Pharmaceutical Development Momentum :

Growing demand for protein expression technologies in drug discovery and development pipelines across the region reflects strengthening pharmaceutical sectors and rising healthcare innovation investments.

Rest Of Latin America Protein Expression Market Dynamics

The region's 7.1% CAGR reflects growing adoption of advanced protein expression systems among pharmaceutical manufacturers and research institutions seeking cost-effective solutions. Key drivers include expanding pharmaceutical development activities, rising government support for life sciences research, and growing partnerships with global biotech firms.
As healthcare spending increases across the region and local expertise develops, Rest Of Latin America is expected to capture greater market share in protein expression technologies, supporting both domestic drug development and contract manufacturing opportunities..

Related Ecosystem

Biotechnology

Top Technologies

Reagents
Polymerase Chain Reaction (PCR)
Stem Cells
Assay Kits
Flow Cytometers

Top Companies

Thermo Fisher Scientific Inc.
Merck KGaA
Danaher Corporation
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.

Key Takeaways

Rest Of Latin America's protein expression market is valued at $46.9 million in 2026 and is forecast to reach $66.2 million by 2031, representing a 7.1% CAGR.
Rest Of Latin America is experiencing increased adoption of mammalian and microbial expression systems driven by pharmaceutical and biotechnology sector expansion.
Rest Of Latin America's market growth is supported by improving regulatory frameworks and rising collaboration with international contract research organizations.
Rest Of Latin America is emerging as a cost-effective hub for protein expression and biologics manufacturing, attracting regional and global investment.

Protein Expression Market Report Scope

Report Metric	Details
Base Year	2026
Fastest Growing Segment	SOFTWARE (Type)
Forecast Period	2026�2031
Growth Rate	CAGR of 8.3% from 2026 to 2031
Largest Segment	PRODUCTS (Offering)
Market Size Base Year (Billions)	~USD 5.13 (2026)
Revenue Forecast (Billions)	~USD 7.65 (2031)
Segments Covered	Offering, Type, End User, Workflow, Scale Of Operation, Protein Modality, Application

Rest Of Latin America Protein Expression Market Report Segmentation

7 segment dimensions are covered across the global market.

By Offering

Products
Services

By Type

Algal & Plant-Based Expression Systems
Algal-Based Expression Systems
Analytical Instruments
Bacillus Systems
Baculovirus Systems
Bioreactors & Fermenters
Cell-Free Expression Systems
Cho Cell Systems
Chromatography & Purification Consumables
Chromatography Systems
Cld Services
Cloning & Mutagenesis Kits
Competent Cells
Consumables
Culture Media & Supplements
Custom Protein Expression Services
E. Coli Lysate-Based Systems
E. Coli Systems
Expression Kits
Expression Vectors & Plasmids
Filtration & Separation Consumables
Filtration Systems
Gene Synthesis & Cloning Services
Hek 293 Cell Systems
Insect Cell Expression Systems
Instruments
Kits
Liquid Handling & Automation Systems
Mammalian Cell Expression Systems
Other Cell-Free Expression Systems
Other Consumables
Other Insect Cell Expression Systems
Other Instruments
Other Kits
Other Mammalian Cell Expression Systems
Other Prokaryotic Expression Systems
Other Reagents
Other Yeast Expression Systems
Pichia Systems
Process Development & Scale-Up Services
Prokaryotic Expression Systems
Reagents
Saccharomyces Systems
Software
Transduction & Transfection Reagents
Yeast Expression Systems

By End User

Academic & Research Institutes
Cros & Cdmos
Other End Users
Pharmaceutical & Biotechnology Companies

By Workflow

Cloning & Transfection
Extraction, Purification, And Characterization
Transcription, Translation, And Post-Translational Modification (Ptm)

By Scale Of Operation

Discovery & Research Scale
Preclinical & Characterization Scale
Process Development & Pilot Scale

By Protein Modality

Enzymes & Catalytic Proteins
Monoclonal Antibodies & Derivatives
Other Proteins
Recombinant Therapeutic Proteins
Vaccines

By Application

Diagnostic Applications
Industrial Applications
Research Applications
Therapeutic Applications

Target Audience

Pharmaceutical Manufacturers : Need region-specific market data to evaluate Rest Of Latin America as a manufacturing hub, assess local demand for protein expression technologies, and plan facility investments.
Biotech Companies : Require detailed insights into Rest Of Latin America's growth potential, emerging research capabilities, and partnership opportunities to guide market entry and expansion strategies.
Investment Firms : Seek targeted market intelligence on Rest Of Latin America's 7.1% CAGR and valuation trajectory to identify investment opportunities in regional biotech and pharmaceutical ventures.
Research Institutions : Need market data on Rest Of Latin America's protein expression adoption rates and funding trends to benchmark research capabilities and secure institutional support for biotechnology initiatives.
Government & Policy Makers : Require regional market analysis to inform biotechnology policy, assess life sciences sector development, and allocate resources for Rest Of Latin America's pharmaceutical and research infrastructure.

Key Companies in the Rest Of Latin America Protein Expression Market

Company	HQ	Ownership	Strongest segments
PATHEON INC	Netherlands	Private Company	Drug Product Services (finished dosage manufacturing & packaging),Pharmaceutical Development Services,Drug Substance Services (small- and large-molecule APIs),
NANOSTRING TECHNOLOGIES, INC	United States	Private Company	nCounter instruments and consumables (Pro, FLEX, SPRINT, CodeSets, panels, reagents),GeoMx DSP and spatial biology solutions,Prosigna and other in vitro diagnostic kits,
BIOGEN	United States	Public Company	Multiple Sclerosis therapies (TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, OCREVUS-related),SPINRAZA and rare neuromuscular (SPINRAZA, QALSODY, SKYCLARYS),Alzheimer�s and neuropsychiatry (LEQEMBI, ZURZUVAE),
SIGMA-ALDRICH CORPORATION	United States	Private Company	Pharma and biopharma manufacturing (media, filtration, critical raw materials, safety testing),Research reagents and molecular biology (chemicals, biochemicals, functional genomics, protein biology),Analytical chemistry, diagnostics, and industrial microbiology,
VIVA BIOTECH LTD	China	Public Company	Discovery biology & structural biology services,Medicinal and synthetic chemistry & CADD,CDMO & CMC/filing services,
CODEXIS, INC.	United States	Public Company	Biopharma process enzymes and custom engineering (CodeEvolver-based),ECO Synthesis and nucleic acid manufacturing solutions,Other life science and industrial enzyme applications,
MAXCYTE, INC	United States	Public Company	ExPERT ATx instruments and related consumables,ExPERT STx instruments and related consumables,ExPERT GTx instruments and related consumables,
THERMO FISHER SCIENTIFIC INC.	United States	Public Company	Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
MERCK KGAA	Germany	Public Company	Life Science (reagents, consumables, bioprocessing, CDMO),Healthcare (oncology, neurology, fertility, rare diseases),Electronics (semiconductor and display materials, delivery equipment),
DANAHER CORPORATION	United States	Public Company	Biotechnology (bioprocessing and bioproduction),Life Sciences (research and analytical instruments, genomics),Diagnostics (clinical instruments and consumables),
AGILENT TECHNOLOGIES, INC.	United States	Public Company	Life Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets,
SARTORIUS AG	Germany	Public Company	Bioprocess solutions (bioreactors, cell culture, fluid management, process filtration),Analytical solutions (BLI, cytometry screening, PAT, live-cell imaging, SPR),Lab products and services (filtration, purification, lab water, weighing, pipettes, microbiological testing),
GENSCRIPT	Hong Kong	Public Company	Life Science Services and Products,Biologics Development Services,Industrial Synthetic Biology Products,
TAKARA BIO INC.	Japan	Private Company	Genetic and cellular research reagents,Instruments and cellular analysis devices,In vitro diagnostics (including COVID-19),
BIO-RAD LABORATORIES, INC.	United States	Public Company	Clinical Diagnostics,Life Science Research Instruments and Reagents,Other / Software and Services,
QIAGEN	Netherlands	Public Company	Sample technologies (extraction and purification consumables/instruments),PCR and enzymes (qPCR/dPCR instruments and reagents),Molecular diagnostic assays (TB, oncology, sexual and reproductive health, transplant/viral load),
CHARLES RIVER LABORATORIES	United States	Public Company	Research Models and Services,Discovery and Safety Assessment,Manufacturing Solutions,
CORNING INCORPORATED	United States	Public Company	Optical communications (fiber, cable, hardware, equipment),Display glass substrates (LCD/OLED),Specialty materials and mobile consumer electronics glass,
LONZA	Switzerland	Public Company	Integrated Biologics (mammalian and drug product CDMO),Advanced Synthesis (small molecules, HPAPIs, ADCs, bioconjugates),Specialized Modalities (cell & gene, microbial, bioscience, mRNA),
FUJIFILM HOLDINGS CORPORATION	Japan	Public Company	Healthcare (medical systems, CDMO, pharma, regenerative, cosmetics/supplements),Electronics (display, semiconductor, image sensors, functional films, storage),Business Innovation (office equipment, document services, graphic communications),
SYNGENE INTERNATIONAL LIMITED	India	Public Company	Discovery Services (chemistry, biology, computational),Development Services (preclinical, CMC, clinical development),Biologics and Specialty Modalities,
LGC LIMITED	South Korea	Public Company	Ethylene-based synthetic resins (PE, EVA, LLDPE, UNIQABLE),Styrene-based resins (ABS, ASA, PS, EPS, SAN),Polycarbonate and engineering plastics (LUMID/LUXY, LUMILOY, LUPOL, LUPOY, etc.),

PATHEON INC

Patheon Inc is a Netherlands-based private company with 9,100 employees operating in the life sciences sector.

NANOSTRING TECHNOLOGIES, INC

NanoString Technologies, Inc is a United States-based private company founded in 2003 with 550 employees specializing in life sciences technology.

BIOGEN

Biogen is a United States-based public company founded in 1978 with 7,500 employees engaged in biotechnology and pharmaceutical development.

SIGMA-ALDRICH CORPORATION

Sigma-Aldrich Corporation is a United States-based private company founded in 1951 with 9,800 employees providing life sciences products and services.

VIVA BIOTECH LTD

Viva Biotech Ltd is a China-based public company founded in 2008 with 2,169 employees providing drug discovery and development services.

CODEXIS, INC.

Codexis, Inc is a United States-based public company founded in 2002 with 146 employees focused on enzyme engineering and biocatalysis.

MAXCYTE, INC

MaxCyte, Inc is a United States-based public company founded in 1998 with 91 employees specializing in cell engineering technology.

THERMO FISHER SCIENTIFIC INC.

Thermo Fisher Scientific Inc is a United States-based public company founded in 1956 with 125,000 employees serving the life sciences and laboratory sectors globally.

MERCK KGAA

Merck KGaA is a Germany-based public company founded in 1668 with 59,077 employees operating as a diversified pharmaceutical and chemical company.

DANAHER CORPORATION

Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees engaged in life sciences, diagnostics, and environmental solutions.

AGILENT TECHNOLOGIES, INC.

Agilent Technologies, Inc is a United States-based public company founded in 1999 with 18,000 employees providing analytical instruments and life sciences solutions.

SARTORIUS AG

Sartorius AG is a Germany-based public company founded in 1870 with 14,242 employees specializing in laboratory and bioprocess equipment.

GENSCRIPT

GenScript is a Hong Kong-based public company founded in 2002 with 6,165 employees providing biotechnology research services and products.

TAKARA BIO INC.

Takara Bio Inc is a Japan-based private company founded in 2002 with 1,779 employees specializing in biotechnology research tools and services.

BIO-RAD LABORATORIES, INC.

Bio-Rad Laboratories, Inc is a United States-based public company founded in 1952 with 7,450 employees manufacturing life sciences research and clinical diagnostics products.

QIAGEN

Qiagen is a Netherlands-based public company founded in 1984 with 5,500 employees providing molecular diagnostics and life sciences research solutions.

CHARLES RIVER LABORATORIES

Charles River Laboratories is a United States-based public company founded in 1947 with 19,000 employees providing preclinical and clinical laboratory services.

CORNING INCORPORATED

Corning Incorporated is a United States-based public company founded in 1851 with 67,200 employees manufacturing specialty glass and materials for life sciences applications.

LONZA

Lonza is a Switzerland-based public company founded in 1897 with 20,000 employees providing pharmaceutical and biotechnology manufacturing services.

FUJIFILM HOLDINGS CORPORATION

Fujifilm Holdings Corporation is a Japan-based public company founded in 1934 with 73,526 employees operating across imaging, pharmaceuticals, and life sciences sectors.

SYNGENE INTERNATIONAL LIMITED

Syngene International Limited is an India-based public company founded in 1993 with 6,692 employees providing drug discovery and development services.

LGC LIMITED

LGC Limited is a South Korea-based public company founded in 1947 with 14,019 employees operating in life sciences and analytical testing services.

Reasons to Buy this Report

Regional Market Sizing : Obtain precise valuation data specific to Rest Of Latin America ($46.9M in 2026), enabling accurate budget allocation and market entry strategies tailored to this emerging region's unique dynamics.
Growth Trajectory Insights : Understand the 7.1% CAGR and $66.2M 2031 projection to identify expansion opportunities and competitive positioning within Rest Of Latin America's accelerating biotechnology sector.
Investment Decision Support : Access region-specific market intelligence to evaluate investment viability, assess pharmaceutical development trends, and identify high-potential markets within Rest Of Latin America for expansion.
Competitive Landscape Analysis : Benchmark performance against regional growth rates and identify market gaps specific to Rest Of Latin America's protein expression segment for strategic differentiation.
Stakeholder Alignment : Present data-driven insights to investors, boards, and partners with Rest Of Latin America-focused metrics, supporting business cases for regional partnerships and market development initiatives.

Frequently asked questions

What is the current market size of protein expression in Rest Of Latin America?

Rest Of Latin America's protein expression market is estimated at $46.9 million in 2026 and is projected to grow to $66.2 million by 2031.

What is the growth rate for protein expression in Rest Of Latin America?

Rest Of Latin America's protein expression market is expected to grow at a compound annual growth rate (CAGR) of 7.1% from 2026 to 2031.

Which expression systems are most commonly used in Rest Of Latin America?

Rest Of Latin America predominantly utilizes mammalian and microbial expression systems, with increasing adoption of insect and plant-based platforms for specialized applications.

What factors are driving growth in Rest Of Latin America's protein expression market?

Rest Of Latin America's market growth is driven by increased pharmaceutical R&D investment, expanding biotechnology infrastructure, improving regulatory frameworks, and rising demand for biologics.

Who are the primary end-users of protein expression services in Rest Of Latin America?

Rest Of Latin America's primary end-users include pharmaceutical companies, contract research organizations, academic institutions, and emerging biotechnology firms focused on therapeutic protein development.

RESEARCH METHODOLOGY

This study involved four major activities in estimating the current size of the protein expression market. Exhaustive secondary research was conducted to gather information on the market, its peer markets, and its parent market. These findings, assumptions, and sizing were then validated with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Following this, the data triangulation procedure was used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was primarily used to identify and gather information for the extensive, technical, market-oriented, and commercial study. The secondary sources referred for this research study include publications from government sources, such as the National Center for Biotechnology Information (NCBI), National Institutes of Health (NIH), World Health Organization (WHO), Food and Drug Administration (FDA), European Medicines Agency (EMA), Pharmaceutical Research and Manufacturers of America (PhRMA), Global Cancer Observatory (GLOBOCAN), Centers for Disease Control and Prevention (CDC), and European Federation of Biotechnology,. Secondary sources also included corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. These sources were also used to obtain key information on major players, global product revenues, market classification, and segmentation by industry trends, regional/country-level markets, market developments, and technology perspectives. Secondary data were collected and analyzed to determine the overall size of the global protein expression market, and the findings were validated through primary research.

Primary Research

In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and assess market prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Protein Expression Market
Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the protein expression market was estimated through multiple approaches. A detailed market estimation approach was used to estimate and validate the market value and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Protein Expression Market : Top-Down and Bottom-Up Approach

Data Triangulation

After estimating the overall market size from the market size estimation process, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments, the data triangulation procedure was employed; it involved studying various factors and trends from both the demand and supply sides.

Market Definition

The protein expression market encompasses the technologies, products, and services required for protein production and analysis. This market includes various expression systems (mammalian, bacterial, yeast, algal, insect, and cell-free), reagents and instruments for transfection and cloning, growth reagents for cell culture during translation, and reagents and kits for downstream processes such as purification and characterization. It serves industries such as pharmaceuticals, biotechnology, academic & research institutes, CROs & CDMOs, and other industrial users, supporting applications in drug discovery, therapeutic development, and biochemical research, as well as other industries such as food and beverages, cosmetics, and textiles, among others.

Key Stakeholders

Protein Expression Instrument & Reagent Manufacturers
Suppliers of Expression Systems
National and regional research boards and organizations
Research & development companies
Clinical research organizations (CROs)
Contract Manufacturing Organizations (CMOs)
Biotechnology companies
Research laboratories & academic institutes
Market research & consulting firms
Regulatory bodies

Report Objectives

To define, describe, and forecast the protein expression market by offering, type, workflow, scale of operation, protein modality, application, product end user, service end user, and region
To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall protein expression market
To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of the market segments with respect to six regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, and the Rest of Latin America), the Middle East [GCC (Saudi Arabia, United Arab Emirates, and the Rest of GCC) and the Rest of Middle East], and Africa
To profile the key players and analyze their market shares and core competencies
To track and analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions
To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

Customization Options

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographical Analysis

Further breakdown of the Rest of Europe protein expression market, by country
Further breakdown of the Rest of Asia Pacific protein expression market, by country

Segment Analysis

Cross-segment analysis

Get the Full Protein Expression Market Report

Full forecast, segment splits, and company analysis for all Protein Expression Market.

Download Sample Pages Buy Report

REPORT COVERAGE

＋

Report Description
Market Overview
Market Dynamics
Related Ecosystem
Key Takeaways
Market Scope
Report Segmentation
Target Audience
Key Companies

Market Size in	USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered	Value (USD MN)